Sk Shehan Hossain | Biochemistry, Genetics and Molecular Biology | Young Scientist Award

Published on by Academic Excellence

Young Scientist Award

Sk Shehan Hossain
Regional Institute of Biotechnology, India

Sk Shehan Hossain
Affiliation Regional Institute of Biotechnology
Country India
Documents 3
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Excellence Awards
ORCID 0009-0004-7544-4607

Sk Shehan Hossain is an emerging researcher affiliated with the Regional Institute of Biotechnology, India. His scholarly activities are centered on microbiology, molecular biology, bioinformatics, and computational approaches in biological sciences. Through a combination of molecular characterization and in silico investigations, he has contributed to the documentation of microbial genetic resources and the exploration of biologically active compounds. His research profile demonstrates early-stage scientific productivity supported by publicly accessible datasets and preprint dissemination platforms.[1][3]

Abstract

This article presents an overview of the research profile of Sk Shehan Hossain in the context of the Young Scientist Award. His work includes microbial genetic identification through 16S ribosomal RNA sequencing and computational evaluation of naturally occurring compounds with potential biomedical relevance. The combination of laboratory-supported microbial studies and bioinformatics-based investigations reflects an interdisciplinary approach aligned with contemporary life science research.[2][3]

Keywords

Microbiology, Molecular Biology, Bacillus Species, 16S rRNA Sequencing, Bioinformatics, Computational Biology, Acetylcholinesterase Inhibitor, Biotechnology.

Introduction

Modern biotechnology increasingly integrates experimental and computational methodologies to address biological questions. Researchers working in this domain contribute to microbial characterization, genomic documentation, and the identification of bioactive compounds. Sk Shehan Hossain’s recent works reflect these trends through publicly archived sequence records and computational studies examining therapeutic potential in natural products.[2][3]

Research Profile

The research activities of Sk Shehan Hossain focus on biological characterization, microbial taxonomy, and computational analysis of biologically significant compounds. His profile demonstrates engagement with open scientific repositories and the dissemination of research findings through internationally accessible platforms. The available publications indicate a commitment to generating foundational scientific knowledge within biotechnology and molecular biology.[1]

Research Contributions

  • Documentation of Bacillus cereus strain AKANKSHYAYTB through 16S rRNA gene sequence submission.
  • Identification and reporting of Bacillus safensis strain BISAMLANWB genetic sequence data.
  • Computational evaluation of suaveolic acid as a potential acetylcholinesterase inhibitor.
  • Promotion of open scientific data accessibility through recognized repositories.

Publications

  1. Bacillus cereus strain AKANKSHYAYTB 16S ribosomal RNA gene, partial sequence (NCBI GenBank, 2026).
  2. Bacillus safensis strain BISAMLANWB 16S ribosomal RNA gene, partial sequence (NCBI GenBank, 2026).
  3. In Silico Investigation of Suaveolic Acid from Mesosphaerum suaveolens as an Acetylcholinesterase Inhibitor (Preprint, 2026).

Research Impact

The documented outputs contribute to publicly available scientific resources used by researchers in microbiology and biotechnology. Sequence submissions enrich genomic databases, while computational investigations provide preliminary insights that may support future experimental validation. Such contributions are valuable for advancing reproducibility, accessibility, and collaborative research within the life sciences.[2][3]

Award Suitability

The Young Scientist Award recognizes emerging researchers who demonstrate scientific promise and meaningful scholarly engagement. Based on the available record, Sk Shehan Hossain has established an early research portfolio encompassing molecular biology, microbial genetics, and computational biotechnology. His documented contributions and commitment to open scientific dissemination align with the objectives commonly associated with early-career research recognition programs.[4]

Conclusion

Sk Shehan Hossain represents a developing researcher whose work integrates microbial characterization and computational biological analysis. Through sequence database contributions and bioinformatics-based investigations, he has demonstrated engagement with contemporary scientific methodologies. His academic activities reflect the characteristics of an emerging scientist contributing to biotechnology and molecular biology research.

References

  1. Elsevier. (n.d.). ORCID author details: Sk Shehan Hossain.
  2. NCBI GenBank. (2026). Bacillus cereus strain AKANKSHYAYTB 16S ribosomal RNA gene, partial sequence.
    https://www.ncbi.nlm.nih.gov/nuccore/PZ619927
  3. Zenodo. (2026). In Silico Investigation of Suaveolic Acid from Mesosphaerum suaveolens as an Acetylcholinesterase Inhibitor.
    https://doi.org/10.5281/ZENODO.18837832
  4. International Academic Excellence Awards. (n.d.). Award recognition framework and evaluation criteria.
    academicexcellenceawards.com
  5. NCBI GenBank. (2026). Bacillus safensis strain BISAMLANWB 16S ribosomal RNA gene, partial sequence.
    https://www.ncbi.nlm.nih.gov/nuccore/PZ619164.1/

Asif Bilal | Biochemistry | Excellence in Research

Published on by Academic Excellence

Dr. Asif Bilal | Biochemistry | Excellence in Research

The Superior University Lahore | Pakistan

Mr. Asif Bilal is a dedicated researcher and academician specializing in Zoology, Cancer Biology, and Molecular Genetics. He earned his MPhil in Zoology from the University of Lahore, where he conducted research on Ringneck Pheasant (Phasianus colchicus) sperm cryopreservation. Currently pursuing a PhD in Zoology at the University of Okara, his doctoral research focuses on in-silico analysis of breast cancer, integrating bioinformatics and computational modeling to understand disease mechanisms and therapeutic targets. With a strong academic foundation, Mr. Bilal has also contributed significantly to academia as a Lecturer of Zoology and Program Coordinator for MS/MPhil at Superior University, Sargodha Campus. His diverse research interests encompass disease biology, genetics, cryopreservation, and epidemiology. He serves on the editorial and review boards of several international journals, including Primera Scientific Medicine and Public Health and Molecular & Cellular Oncology. Mr. Bilal has authored and co-authored over 60 scientific publications and book chapters, covering topics such as cancer genomics, toxicology, zoonotic diseases, and computational drug discovery. His research has been presented at numerous international conferences in Pakistan, Saudi Arabia, and Azerbaijan. Beyond his scientific contributions, he actively promotes scientific literacy through seminars, workshops, and public engagement on health and environmental issues. His commitment to advancing research in molecular and disease biology underscores his role as a promising young scientist dedicated to improving human and animal health through innovative biological research.

Profiles: Orcid | Google Scholar

Featured Publications

Bilal, A. (2021). Rabies is a zoonotic disease: A literature review. Occupational Medicine and Health Affairs, 9(3), 3.

Shah, S. A. H., Bilal, A., Ahmad, M. M., & Bukhari, S. S. (2022). Deforestation is causing a great loss in avian diversity in Pakistan. American Journal of Zoology, 5(3), 24–29.

Bilal, A. (2021). Clinical diagnosis and treatment of absence seizures: Case study. Progress in Medical Sciences, 5(1), 1–3.

Sajjad, M. K., Bilal, A., Iftikhar, A., Awais, M., Asif, I., Shaheen, F., & Zahoor, G. (2024). Examining the association between pesticide exposures and chronic diseases in agricultural workers. Remittances Review, 9(2), 2153–2176.

Khan, I., Bilal, A., Shakeel, K., & Malik, F. T. (2022). Effects of nickel toxicity on various organs of the Swiss albino mice. Uttar Pradesh Journal of Zoology, 43, 1–12.

Siying Li | Cardiovascular diseases | Best Researcher Award

Published on by Academic Excellence

Dr. Siying Li | Cardiovascular diseases | Best Researcher Award

Dr. Siying Li, Central Hospital affiliated to Shandong First Medical University, China

Dr. Siying Li is an Associate Research Fellow at the Metabolism and Disease Research Center, Central Hospital affiliated with Shandong First Medical University, China. She holds a Ph.D., M.M., and M.B. from Shandong University and has conducted postdoctoral research in cardiometabolic diseases. Her work focuses on hydrogen sulfide regulation in mitochondria, autophagy in heart failure, and ferroptosis in metabolic disorders. With experience as a Visiting Scholar at the University of South Carolina, U.S., she has contributed significantly to medical research. Her findings have been widely recognized, making her a leading researcher in metabolism and cardiovascular health.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Siying Li’s academic journey is marked by excellence and dedication to medical research. She earned her Ph.D. (2010-2015), M.M. (2009-2010), and M.B. (2003-2009) from Shandong University, China, a prestigious institution known for its contributions to medical science. Her strong academic foundation laid the groundwork for her specialization in metabolism and disease research, with a keen focus on cardiometabolic disorders.

💼 PROFESSIONAL ENDEAVORS:

Dr. Li’s career progression reflects her commitment to medical research and academia. She is currently an Associate Research Fellow at the Metabolism and Disease Research Center, Central Hospital affiliated with Shandong First Medical University (2023-Present). Previously, she held key research positions, including:
🔹 Associate Research Fellow at the Shandong Institute of Endocrine and Metabolic Disease (2021-2023)
🔹 Assistant Research Fellow at the Department of Pathophysiology, School of Basic Medicine, Shandong University (2017-2020)
🔹 Postdoctoral Researcher at Shandong University (2015-2017)
🔹 Visiting Scholar at the University of South Carolina, U.S. (2011-2013)

Her extensive experience in both national and international institutions has provided her with a global perspective on medical research, fostering interdisciplinary collaborations.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Dr. Li’s research is centered on cardiometabolic diseases, an area of growing significance in modern medicine. Her key research contributions include:
✅ Hydrogen Sulfide & Mitochondria in Heart Failure – Investigating its regulatory role in cellular metabolism and autophagy.
✅ Iron Metabolism & Ferroptosis in Cardiometabolic Diseases – Exploring its potential in disease progression and therapeutic interventions.

Her work has advanced the understanding of molecular mechanisms in cardiovascular health, paving the way for potential breakthroughs in medical treatments.

🌍 IMPACT AND INFLUENCE:

Dr. Li’s research has made a significant impact on the global scientific community, particularly in the fields of metabolism, endocrinology, and cardiovascular health. Her studies on ferroptosis and hydrogen sulfide regulation have influenced new treatment approaches for heart failure and metabolic disorders. Her collaborations with leading research institutions and hospitals have further amplified the clinical relevance of her findings.

📚 ACADEMIC CITATIONS AND RECOGNITION:

Dr. Li’s work has been widely recognized in peer-reviewed journals and international conferences. Her research has garnered numerous citations, reflecting its significance and contribution to the medical field. She has also actively participated in academic symposiums and medical panels, sharing her insights with researchers worldwide.

🚀 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Li’s ongoing research promises to make groundbreaking contributions to medicine. Her expertise in molecular metabolism and cardiovascular pathophysiology positions her as a key figure in the future of personalized medicine and targeted therapies. Her dedication to advancing scientific knowledge and mentoring young researchers ensures a lasting impact on the field of medical science.

🏅 CONCLUSION:

Dr. Siying Li is a distinguished researcher whose contributions to cardiometabolic diseases have significantly advanced medical science. Her expertise in hydrogen sulfide regulation, mitochondrial function, and ferroptosis has provided valuable insights into heart failure and metabolic disorders. With a strong academic background, extensive research experience, and international collaborations, she has established herself as a leading scientist in her field. Her work not only enhances fundamental understanding but also paves the way for innovative therapeutic approaches.

TOP NOTABLE PUBLICATIONS

The potential role of hydrogen sulfide in regulating macrophage phenotypic changes via PINK1/parkin-mediated mitophagy in sepsis-related cardiorenal syndrome

Authors: Chen, Y., Cao, W., Li, B., … Yang, G., Li, S.

Journal: Immunopharmacology and Immunotoxicology

Year: 2024

Cyclophilin D as a potential therapeutic target of liver ischemia/reperfusion injury by mediating crosstalk between apoptosis and autophagy

Authors: Yang, M., Wang, Z., Xie, J., … Li, S., Song, Y.

Journal: Chronic Diseases and Translational Medicine

Year: 2023

 Urine proteomics for profiling of mouse toxoplasmosis using liquid chromatography tandem mass spectrometry analysis

Authors: Cui, L.-L., Zhou, C.-X., Han, B., … Xie, S.-C., Zhou, D.-H.

Journal: Parasites and Vectors

Year: 2021

S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways

Authors: Mo, M., Li, S., Dong, Z., … Li, A., Zhao, Z.

Journal: International Immunopharmacology

Year: 2020

The key role of macrophage depolarization in the treatment of COPD with ergosterol both in vitro and in vivo

Authors: Sun, X., Liu, Y., Feng, X., … Li, S., Zhao, Z.

Journal: International Immunopharmacology

Year: 2020

S-allylmercaptocysteine targets NRF2 in osteoarthritis treatment through NOX4/NF-ΚB pathway

Authors: Yang, G., Sun, S., Wang, J., … Yuan, L., Li, S.

Journal: Drug Design, Development and Therapy

Year: 2020

 A nucleoside/nucleobase-rich extract from Cordyceps sinensis inhibits the epithelial-mesenchymal transition and protects against renal fibrosis in diabetic nephropathy

Authors: Dong, Z., Sun, Y., Wei, G., Li, S., Zhao, Z.

Journal: Molecules

Year: 2019

Ergosterol attenuates cigarette smoke extract-induced COPD by modulating inflammation, oxidative stress and apoptosis in vitro and in vivo

Authors: Sun, X., Feng, X., Zheng, D., … Li, S., Zhao, Z.

Journal: Clinical Science

Year: 2019

 Yifei tongluo, a Chinese herbal formula, suppresses tumor growth and metastasis and exerts immunomodulatory effects in Lewis lung carcinoma mice

Authors: Qi, Q., Hou, Y., Li, A., … Li, S., Zhao, Z.

Journal: Molecules

Year: 2019

Ergosterol ameliorates diabetic nephropathy by attenuating mesangial cell proliferation and extracellular matrix deposition via the TGF-β1/Smad2 signaling pathway

Authors: Dong, Z., Sun, Y., Wei, G., Li, S., Zhao, Z.

Journal: Nutrients

Year: 2019